About us

Directors & Staff

The ALS Therapy Alliance is fortunate to have a Board of Directors comprised of talented clinicians, scientists and business associates who are committed to the organization’s mission.

With the board’s supervision, more than $30 million dollars has been generated to execute a wide range of research programs, which now involve multiple institutions in several countries.

Board of Directors: Robert H. Brown | Gregory Petsko | Lawrence J. Hayward | H. Robert Horvitz | Tom Maniatis | Craig C. Mello | Merit E. Cudkowicz | Jonathan Roberts | David Schwartz

Read More

History & Mission

The ALS Therapy Alliance (ATA) was established in 2000 to facilitate ALS research projects and collaborations among a diverse group of scientists and clinicians at multiple institutions to cure ALS. This represents a unique collaborative enterprise that spans multiple laboratories, universities and disciplines.

ALS (amyotrophic lateral sclerosis), also know as Lou Gehrig’s Disease, is a disorder that causes progressive paralysis leading to respiratory failure and death typically in 4 to 6 years. The disease remains uniformly lethal, and its cause remains unknown.

The ALS Therapy Alliance (ATA) was established in 2000 to facilitate ALS research projects and collaborations among a diverse group of scientists and clinicians at multiple institutions to cure ALS. This represents a unique collaborative enterprise that spans single laboratories and universities.

Today, the ATA partners with corporations, biotech and pharmaceutical firms, manufacturers and the media to create awareness and raise funds for research of ALS through its annual Breakthrough ALS campaign.

Read More